Catalyst Wire Dossier Catalyst Wire Dossier

ND1 gene therapy

· Neurophth Therapeutics Inc
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ND1 gene therapy, covering 2024-09-20 to 2024-09-20. Get the full timeline:

Most recent: Clinical Trial Update: Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND1 Mutations [Phase 1, Phase 2]

See pricing